JWH-147: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (no changed fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Wikipedia:WikiProject Chemicals/Chembox validation|Chem/Dru |
No edit summary Tags: Visual edit Mobile edit Mobile web edit |
||
(17 intermediate revisions by 15 users not shown) | |||
Line 1: | Line 1: | ||
{{short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
| IUPAC_name = 1-hexyl-2-phenyl-4-(1-naphthoyl)pyrrole |
|||
⚫ | |||
⚫ | |||
| IUPAC_name = (1-Hexyl-5-phenyl-1''H''-pyrrol-3-yl)-1-naphthalenyl-methanone |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Clinical data--> |
|||
⚫ | |||
| tradename = |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| legal_US = Schedule I |
|||
⚫ | |||
⚫ | |||
<!--Pharmacokinetic data--> |
|||
⚫ | |||
⚫ | |||
| metabolism = |
|||
⚫ | |||
⚫ | |||
<!--Identifiers--> |
|||
| CAS_number_Ref = {{cascite|correct|CAS}} |
|||
⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = MQ6N4B8QWE |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank |
| DrugBank = |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| C=27|H=27|N=1|O=1 |
|||
| ChemSpiderID = 23277882 |
|||
| molecular_weight = 381.51 g/mol |
|||
⚫ | |||
⚫ | |||
<!--Chemical data--> |
|||
⚫ | |||
| |
| C=27 | H=27 | N=1 | O=1 |
||
⚫ | |||
⚫ | |||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
⚫ | |||
| StdInChI = 1S/C27H27NO/c1-2-3-4-10-18-28-20-23(19-26(28)22-13-6-5-7-14-22)27(29)25-17-11-15-21-12-8-9-16-24(21)25/h5-9,11-17,19-20H,2-4,10,18H2,1H3 |
|||
⚫ | |||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
⚫ | |||
| StdInChIKey = FRMYAMAGHYHNKF-UHFFFAOYSA-N |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|||
⚫ | |||
⚫ | |||
}} |
}} |
||
'''JWH-147''' is an [[analgesic]] drug used in scientific research, which acts as a [[cannabinoid]] agonist at both the [[cannabinoid receptor 1|CB<sub>1</sub>]] and [[cannabinoid receptor 2|CB<sub>2</sub>]] [[Receptor (biochemistry)|receptors]]. It is somewhat selective for the CB<sub>2</sub> subtype, with a [[Dissociation constant| |
'''JWH-147''' is an [[analgesic]] drug used in scientific research, which acts as a [[cannabinoid]] [[agonist]] at both the [[cannabinoid receptor 1|CB<sub>1</sub>]] and [[cannabinoid receptor 2|CB<sub>2</sub>]] [[Receptor (biochemistry)|receptors]]. It is somewhat selective for the CB<sub>2</sub> subtype, with a [[Dissociation constant|K<sub>i</sub>]] of 11.0 nM at CB<sub>1</sub> vs 7.1 nM at CB<sub>2</sub>.<ref name="pmid16889960">{{cite journal | vauthors = Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR | title = 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors | journal = Bioorganic & Medicinal Chemistry Letters | volume = 16 | issue = 20 | pages = 5432–5 | date = October 2006 | pmid = 16889960 | doi = 10.1016/j.bmcl.2006.07.051 }}</ref> It was discovered and named after the renowned professor of organic chemistry [[John W. Huffman]]. |
||
==Legal status== |
|||
In the United States, CB<sub>1</sub> receptor agonists of the 3-(1-naphthoyl)pyrrole class such as JWH-147 are [[Schedule I Controlled Substance]]s.<ref>{{UnitedStatesCode2|21|812|Schedules of controlled substances}}</ref> |
|||
JWH-147 was banned in Sweden on 1 October 2010 as harmful to health, after being identified as an ingredient in "herbal" [[synthetic cannabis]] products.<ref>[http://www.riksdagen.se/webbnav/index.aspx?nid=3911&bet=1999:58 Swedish Code of Statutes Regulation (2010:1086).]</ref><ref>{{Cite web |url=http://www.lagboken.se/files/SFS/2010/101086.PDF |title=Swedish Code of Statutes Regulation (2010:1086). (pdf) |access-date=2011-01-10 |archive-url=https://web.archive.org/web/20110728111705/http://www.lagboken.se/files/SFS/2010/101086.PDF |archive-date=2011-07-28 |url-status=dead }}</ref> |
|||
==See also== |
==See also== |
||
Line 36: | Line 61: | ||
==References== |
==References== |
||
{{Reflist}} |
|||
<references/> |
|||
{{Cannabinoids}} |
{{Cannabinoids}} |
||
⚫ | |||
[[Category: |
[[Category:CB1 receptor agonists]] |
||
[[Category: |
[[Category:CB2 receptor agonists]] |
||
⚫ |